General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The cellular allograft market is segmented into usage for the cervical and lumbar regions of the spine. The cellular allograft market is the fastest growing within the overall bone graft market. By far, the largest market segment was for lumbar usage, with the remainder going to cervical. Both segments are growing rapidly, which will continue over the forecast period. Contributing to the larger market share of the lumbar segment is that much more graft material is required for lumbar usage. Use of stem cell grafts outside of the spine will also see growth; this should bring an even greater market potential for stem cell grafts.
The high average selling price (ASP) of cellular allografts has provided incentives for new players to enter the market. The synergies between the bone graft substitute materials such as allografts and DBMs provide a platform for companies that operate within those markets to pursue growth by expanding into cellular allograft market.
'
TABLE OF CONTENTS I
LIST OF FIGURES XVIII
LIST OF CHARTS XX
EXECUTIVE SUMMARY 1
U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
PROCEDURE NUMBERS 9
MARKETS INCLUDED 11
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.1.1 Osteology and Musculoskeletal System 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 General Diagnostic 28
2.2.2 Osteoporosis 29
2.2.3 Osteoarthritis 29
2.2.4 Indication for Bone Graft Procedure 30
2.2.5 Indication for Cartilage Repair 31
2.2.6 Degenerative Disc Disease 32
2.3 PATIENT DEMOGRAPHICS 34
2.3.1 General Statistics 34
PRODUCT ASSESSMENT 36
3.1 PRODUCT PORTFOLIOS 36
3.1.1 Cellular Allografts 37
3.2 CLINICAL TRIALS 41
3.2.1 Cellular Allografts 41
CELLULAR ALLOGRAFT MARKET 47
4.1 INTRODUCTION 47
4.1.1 Lineage 48
4.1.1.1 Human Embryonic Stem Cells (hESC) 48
4.1.1.2 Mesenchymal Stem Cells (MSC) 48
4.1.2 Other Therapeutic Applications 48
4.2 MARKET OVERVIEW 50
4.3 MARKET ANALYSIS AND FORECAST 53
4.3.1 Total Cellular Allograft Market 53
4.3.1.1 Cervical Spine Stem Cell Market 55
4.3.1.2 Lumbar Spine Stem Cell Market 57
4.4 DRIVERS AND LIMITERS 59
4.4.1 Market Drivers 59
4.4.2 Market Limiters 60
4.5 COMPETITIVE MARKET SHARE ANALYSIS 62
ABBREVIATIONS 66
APPENDIX II: COMPANY PRESS RELEASES 68
Chart 1 1: Orthopedic Biomaterials Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023 3
Chart 4 1: Orthopedic Cellular Allograft Market by Segment, U.S., 2013 – 2023 51
Chart 4 2: Orthopedic Cellular Allograft Market Breakdown, U.S., 2016 52
Chart 4 3: Orthopedic Cellular Allograft Market Breakdown, U.S., 2023 52
Chart 4 4: Total Orthopedic Cellular Allograft Market, U.S., 2013 – 2023 54
Chart 4 5: Cervical Spine Stem Cell Market, U.S., 2013 – 2023 56
Chart 4 6: Lumbar Spine Stem Cell Market, U.S., 2013 – 2023 58
Chart 4 7: Leading Competitors, Orthopedic Stem Cell Market, U.S., 2016 65
MedtronicGenzymeDePuy SynthesAnika TherapeuticsFerring PharmaceuticalsStrykerNuVasiveBioventusZimmer BiometIntegra LifeSciencesRTI SurgicalFidia PharmaceuticalsMTFOrthofixArthrexAlloSourceAastromBaxterHarvest TechnologiesWright MedicalBacterin InternationalArteriocyteExactechLifeNet HealthBiocompositesAlphatec SpineCelling BiosciencesGlobus MedicalNuo TherapeuticsK2M*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.